Compounds > nevirapine

nevirapine and thiourea

nevirapine has been researched along with thiourea in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's1 (20.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ekstrand, DH; Gronowitz, JS; Källander, CF; Rytting, AS; Shao, X; Vrang, L1
Mao, C; Sudbeck, EA; Uckun, FM; Venkatachalam, TK1
Chamberlain, PP; Ferris, R; Nichols, CE; Ren, J; Short, SA; Stammers, DK; Stamp, A; Weaver, KL1
Briñón, MC; Madrid, M; Quevedo, MA; Ribone, SR1
Ariën, KK; Heyndrickx, L; Michiels, J; Quiñones-Mateu, ME; Selhorst, P; Terrazas-Aranda, K; Vanham, G; Vazquez, AC; Vereecken, K; Weber, J1

Other Studies

5 other study(ies) available for nevirapine and thiourea

ArticleYear
Colorimetric assays for evaluation of the mode of action of human immunodeficiency virus type 1 non-nucleoside reverse transcriptase inhibitors.
    Antiviral chemistry & chemotherapy, 1998, Volume: 9, Issue:2

    Topics: Amino Acid Sequence; Anti-HIV Agents; Benzodiazepines; Colorimetry; Delavirdine; Drug Evaluation; Enzyme-Linked Immunosorbent Assay; HIV Reverse Transcriptase; HIV-1; Imidazoles; Molecular Sequence Data; Nevirapine; Pyridines; Recombinant Proteins; Reverse Transcriptase Inhibitors; Templates, Genetic; Thiourea

1998
Rational design of N-[2-(2,5-dimethoxyphenylethyl)]-N'-[2-(5-bromopyridyl)]-thiourea (HI-236) as a potent non-nucleoside inhibitor of drug-resistant human immunodeficiency virus.
    Bioorganic & medicinal chemistry letters, 1999, Jun-07, Volume: 9, Issue:11

    Topics: Anti-HIV Agents; Delavirdine; Drug Design; Humans; Inhibitory Concentration 50; Kinetics; Models, Molecular; Nevirapine; Pyridines; Thiourea

1999
Structural insights into mechanisms of non-nucleoside drug resistance for HIV-1 reverse transcriptases mutated at codons 101 or 138.
    The FEBS journal, 2006, Volume: 273, Issue:16

    Topics: Anti-HIV Agents; Binding Sites; Codon; Crystallography, X-Ray; Drug Design; Drug Resistance, Viral; HIV Reverse Transcriptase; HIV-1; Humans; Models, Molecular; Nevirapine; Pyridines; Reverse Transcriptase Inhibitors; Thiourea

2006
Rational approaches for the design of effective human immunodeficiency virus type 1 nonnucleoside reverse transcriptase inhibitors.
    Journal of chemical information and modeling, 2011, Jan-24, Volume: 51, Issue:1

    Topics: Anti-HIV Agents; Crystallography, X-Ray; Drug Design; HIV Reverse Transcriptase; HIV-1; Inhibitory Concentration 50; Molecular Dynamics Simulation; Mutation; Nevirapine; Protein Conformation; Reverse Transcriptase Inhibitors; Solvents; Thermodynamics; Thiourea

2011
Human immunodeficiency virus type 1 resistance or cross-resistance to nonnucleoside reverse transcriptase inhibitors currently under development as microbicides.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:4

    Topics: Alkynes; Anilides; Anti-Infective Agents; Benzoxazines; Cell Line; Cells, Cultured; Cyclopropanes; Delavirdine; Drug Resistance, Viral; Furans; Genotype; HIV-1; Humans; Nevirapine; Reverse Transcriptase Inhibitors; Thiazoles; Thioamides; Thiourea

2011